Section Arrow
BSX.NYSE
- Boston Scientific Corp
Quotes are at least 15-min delayed:2026/11/20 17:16 EST
After Hours
Last
 42.51
+0.53 (+1.26%)
Bid
41.92
Ask
42.75
High 42.51 
Low 41.88 
Volume 1.03M 
Regular Hours (Closed)
Last
 41.98
-1.01 (-2.35%)
Day High 
43.225 
Prev. Close
42.99 
1-M High
46.97 
Volume 
15.22M 
Bid
41.92
Ask
42.75
Day Low
41.92 
Open
42.77 
1-M Low
39.57 
Market Cap 
62.31B 
Currency 美元 
P/E 18.14 
%Yield -- 
10-SMA 43.85 
20-SMA 44.01 
50-SMA 43.86 
52-W High 101.91 
52-W Low 39.57 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
2.37/3.00
Enterprise Value
73.45B
Balance Sheet
Book Value Per Share
17.68
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
20.07B
Operating Revenue Per Share
9.49
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.51 +0.53 +1.26%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.61 -0.02 -1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.42 -0.52 -0.52%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.963 +0.054 +5.94%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 102.69 -0.31 -0.30%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.